2006
DOI: 10.1111/j.1365-2036.2006.02790.x
|View full text |Cite
|
Sign up to set email alerts
|

Use of tegaserod along with polyethylene glycol electrolyte solution for colonoscopy bowel preparation: a prospective, randomized, double‐blind, placebo‐controlled study

Abstract: SUMMARY BackgroundPolyethylene glycol electrolyte solution (PEG-EL) used for colonoscopy preparation is not well tolerated by several patients. A significant number of patients have inadequate bowel preparation despite taking PEG-EL.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0
2

Year Published

2008
2008
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 26 publications
0
5
0
2
Order By: Relevance
“…However, these investigations have produced substantial heterogeneity and a minority of positive data. The optimum combination of efficacy, tolerability, and safety has yet to be defined for bowel preparation for colonoscopy, and a new modified method for preparation is needed [6,[20][21][22][23][24][25][26].…”
Section: Discussionmentioning
confidence: 99%
“…However, these investigations have produced substantial heterogeneity and a minority of positive data. The optimum combination of efficacy, tolerability, and safety has yet to be defined for bowel preparation for colonoscopy, and a new modified method for preparation is needed [6,[20][21][22][23][24][25][26].…”
Section: Discussionmentioning
confidence: 99%
“…In randomized trials, prokinetics such as metoclopramide, domperidone, cisapride, and tegaserod have not improved patient tolerability or quality of the bowel preparation (175)(176)(177)(178). Mosapride and itopride, 2 motility-enhancing agents currently in clinical development, improved preprocedure tolerability with signifi cant reductions in nausea, vomiting, bloating, and abdominal pain ( 177 ) , and improved effi cacy in patients receiving split-dose preparations ( 178 ).…”
Section: Recommendationsmentioning
confidence: 97%
“…However, use of cisapride in this setting is associated with serious unexpected side effects, so it has been withdrawn from the market [23, 24]. Other prokinetic agents, including domperidone and tegaserod, have been coadministered with oral lavage solution in an attempt to improve the quality of bowel preparation and patient tolerance to lavage solution [25]. However, the required volume of these agents has not yet been clearly established, and the results of studies that have evaluated these agents have thus far been contradictory [13, 14].…”
Section: Discussionmentioning
confidence: 99%